Non-exclusive deal intends to popularize RTU containment solutions within pharma industry
Stevanato Group S.p.A., a provider of drug containment, drug delivery, and diagnostic solutions to the pharma, biotech, and life sciences industries, and DWK Life Sciences, a manufacturer and provider of precision labware as well as primary packaging solutions for the life science research, diagnostics, and pharmaceutical markets, have entered a non-exclusive agreement for the distribution and sale of the EZ-fill ready-to-use solutions (RTU) by Stevanato Group.
The collaboration will leverage DWK Life Sciences’ knowledge in supplying a global network of laboratories and biopharma customers to broaden the distribution of Stevanato Group’s RTU EZ-fill products. RTU containment solutions allow pharma companies to maximize flexibility in aseptic filling using a common filling platform and are able be integrated into existing pharma manufacturing filling lines.
“ … The introduction of the EZ-fill platform supports our strategy to expand best-in-class solutions and services from ‘Discovery to Delivery’ that enable our customers to focus on their efforts to develop and commercialize biopharmaceuticals and therapeutics that improve patient lives,” says Michele Mora, managing director & chief business officer for DWK Life Sciences.